Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 145.24

-1.2%

Dec 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (115)	3/3/1999 7:18:00 AM
From: Laurens	Read Replies (1) of 1834

On balance, I think the AHP deal will overshadow the negative news. I worked 17 years for Wyeth, and I am very pleased they are going to work with NBIX. AHP are not likely to start something if there is not a pretty good chance of getting to a marketable product. Good news indeed! Should put NBIX stock up at least $ 1.- (AHP also has deal with LIPO. The latter stock has been doing great over the past year)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next